Investigation Of a New Oral Anti-Histamine in Healthy Male Subjects
Status:
Completed
Trial end date:
2008-05-03
Target enrollment:
Participant gender:
Summary
This study is designed to assess the safety and tolerability of single, escalating oral doses
and repeat oral doses (7 days, once daily) of GSK835726 in healthy male subjects